Gene · 5932
Papers3,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubiquitination Links DNA Damage and Repair Signaling to Cancer Metabolism. | Int J Mol Sci | 2023 | 37176148 | PubTator, text mining | PubMed |
| Cdc14 phosphatase counteracts Cdk-dependent Dna2 phosphorylation to inhibit resection during recombinational DNA repair. | Nat Commun | 2023 | 37173316 | PubTator, text mining | PubMed |
| Radiotherapy and radio-sensitization in H3K27M -mutated diffuse midline gliomas. | CNS Neurosci Ther | 2023 | 37157237 | PubTator, text mining | PubMed |
| The SETD2 Methyltransferase Supports Productive HPV31 Replication through the LEDGF/CtIP/Rad51 Pathway. | J Virol | 2023 | 37154769 | PubTator, text mining | PubMed |
| Metabolic modulation of CtBP dimeric status impacts the repression of DNA damage repair genes and the platinum sensitivity of ovarian cancer. | Int J Biol Sci | 2023 | 37151877 | PubTator, text mining | PubMed |
| Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe. | Nucleic Acids Res | 2023 | 37144518 | PubTator, text mining | PubMed |
| MSH2-MSH3 promotes DNA end resection during homologous recombination and blocks polymerase theta-mediated end-joining through interaction with SMARCAD1 and EXO1. | Nucleic Acids Res | 2023 | 37140056 | PubTator, text mining | PubMed |
| Proper RPA acetylation promotes accurate DNA replication and repair. | Nucleic Acids Res | 2023 | 37140030 | PubTator, text mining | PubMed |
| ZFP750 affects the cutaneous barrier through regulating lipid metabolism. | Sci Adv | 2023 | 37115925 | PubTator, text mining | PubMed |
| Drug Discovery Targeting Post-Translational Modifications in Response to DNA Damages Induced by Space Radiation. | Int J Mol Sci | 2023 | 37108815 | PubTator, text mining | PubMed |
| Ubiquitin E3 ligases in cancer: somatic mutation and amplification. | BMB Rep | 2023 | 37081755 | PubTator, text mining | PubMed |
| De-ubiquitination of SAMHD1 by USP7 promotes DNA damage repair to overcome oncogenic stress and affect chemotherapy sensitivity. | Oncogene | 2023 | 37081042 | PubTator, text mining | PubMed |
| A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cells. | Nucleic Acids Res | 2023 | 37070192 | PubTator, text mining | PubMed |
| New perspectives on epigenetic modifications and PARP inhibitor resistance in HR-deficient cancers. | Cancer Drug Resist | 2023 | 37065862 | PubTator, text mining | PubMed |
| Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases. | Transl Neurodegener | 2023 | 37055865 | PubTator, text mining | PubMed |
| Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma. | Front Oncol | 2023 | 37025591 | PubTator, text mining | PubMed |
| Replication-associated formation and repair of human topoisomerase IIIα cleavage complexes. | Nat Commun | 2023 | 37024461 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Expanding the phenotype of Seckel syndrome associated with biallelic loss-of-function variants in CEP63. | Am J Med Genet A | 2023 | 37017437 | PubTator, text mining | PubMed |
| TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks. | Nat Commun | 2023 | 37002234 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5932/papers?page=14